SCA
CYTO

Stonebridge Capital Advisors’s Altamira Therapeutics Ltd CYTO Stock Holding History

Stonebridge Capital Advisors’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$1 – 918
2023
Q3 		– Hold
0
– – – 924
2023
Q2 		– Hold
0
– – – 928
2023
Q1 		– Hold
0
– – – 937
2022
Q4 		– Hold
0
– – – 950
2022
Q3 		– Hold
0
– – – 1149
2022
Q2 		– Hold
0
– – – 1108
2022
Q1 		– Hold
0
– – – 1122
2021
Q4 		– Hold
0
– – – 1074
2021
Q3 		– Hold
0
– – – 1141
2021
Q2 		– Hold
0
– – – 1055

Other funds holding CYTO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return